Wellspring Financial Advisors LLC Trims Stake in Sotera Health Company $SHC

Wellspring Financial Advisors LLC lowered its position in shares of Sotera Health Company (NASDAQ:SHC) by 55.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,706 shares of the company’s stock after selling 82,002 shares during the period. Wellspring Financial Advisors LLC’s holdings in Sotera Health were worth $1,141,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in SHC. Empowered Funds LLC lifted its stake in Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after purchasing an additional 43,471 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock worth $293,000 after purchasing an additional 14,018 shares during the last quarter. Creative Planning lifted its stake in Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after purchasing an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after purchasing an additional 12,758 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 15.36% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SHC. The Goldman Sachs Group began coverage on Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price target for the company. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Citigroup lifted their price target on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Barclays dropped their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and an average price target of $20.29.

Sotera Health Trading Down 1.6%

NASDAQ SHC opened at $16.27 on Thursday. Sotera Health Company has a 1-year low of $10.80 and a 1-year high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The stock has a 50-day moving average of $15.54 and a 200-day moving average of $16.38. The firm has a market cap of $4.64 billion, a PE ratio of 39.68 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the previous year, the company posted $0.14 EPS. Sotera Health’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, sell-side analysts forecast that Sotera Health Company will post 0.86 EPS for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.